1. Hengst JC, Mokyr MB, Dray S . Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors. Cancer Res 1981; 41: 2163–2167.
2. Ben-Efraim S, Bocian RC, Mokyr MB, Dray S . Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth. Cancer Immunol Immunother 1983; 15: 101–107.
3. Morikawa K, Hosokawa M, Hamada J, Sugawara M, Kobayashi H . Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma. Cancer Res 1985; 45: 1502–1506.
4. Berd D, Maguire Jr HC, Mastrangelo MJ . Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. Cancer Res 1986; 46: 2572–2577.
5. Sahasrabudhe DM, deKernion JB, Pontes JE, Ryan DM, O’Donnell RW, Marquis DM et al. Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma. J Biol Response Modif 1986; 5: 581–594.